SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes.
暂无分享,去创建一个
H. Kantarjian | A. Stopeck | J. Cortes | S. Verstovsek | J. Cherrington | J. Karp | S. O'brien | F. Giles | M. Albitar | J. Lancet | H. A. Yuen | S. Louie | Weiru Hong | A. Hannah | M. Cooper | L. Silverman | Anne-Marie | Kantarjian | Cortes | A. O'Farrell | E. Jorge | O'farrell. | M. Hagop | Helene A. Yuen